Tezacaftor (VX-661)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tezacaftor (VX-661), covering 2014-03-26 to 2019-01-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor [Phase 3]